News Medical on MSN
Genome-edited immune cell therapy shows promise for treating aggressive blood cancer
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...
A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...
CAR7, has shown remarkable success in reversing an aggressive form of leukemia. This world-first treatment uses genetically ...
Researchers at UCLA have created an “off-the-shelf" cell-based immunotherapy that can seek out and destroy pancreatic cancer ...
News-Medical.Net on MSN
Lymphocyte levels help predict outcomes after CAR T-cell therapy in non-Hodgkin lymphoma
Measuring the lymphocytes - white blood cells that fight infection - in a patient's blood can be used to predict outcomes in ...
A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.
Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive ...
In a recent preclinical study, researchers from The University of Texas MD Anderson Cancer Center developed an antibody ...
Positive results of ERNA-101 in ovarian cancer models demonstrated promising survival benefit and immune activation, ...
Immune cells are generated to keep our bodies healthy. To combat disease, our bodies initiate two separate waves of immunity. The first wave, known as innate immunity, is a generalizable response that ...
Researchers at Stanford found a way to cure or prevent Type 1 diabetes in mice using a combined blood stem cell and islet ...
Born in Morristown, N.J., with virtually no immune system, Cora was diagnosed with severe combined immunodeficiency, a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results